从基层减少伤害的努力中吸取的经验教训 防止药物过量死亡
Ngoc Vuong1, Piper Davis2, Lailani Lemus3
1Psychology, Wichita State University, Wichita, KS, USA.
概括
基于社区的分发纳洛和芬太尼试验条 (FTS) 的计划对于减少危害至关重要. 让受影响的社区参与并解决障碍是有效,可访问的分发的关键.
科学领域:
- 公共卫生 公共卫生
- 社区健康 社区健康
- 药物使用障碍 药物使用障碍
背景情况:
- 由于成本和耻辱,在获得纳洛和芬太尼试验条 (FTS) 方面的不平等需要社区主导的分发.
- 堪萨斯州的阿片类药物流行,特别是威奇塔和塞德威克县,突出了需要可访问的减伤用品的需求.
- 维奇塔的安全街道发起了WORKED项目,这是一个由志愿者领导的项目,提供免费的纳洛和FTS套件.
研究的目的:
- 评估从参与Project WORKED.的利益相关者身上学到的经验教训.
- 收集反,以改善基于社区的减少危害的倡议.
- 为了告知未来的真实性,效率,可访问性和危害降低供应分配的寿命.
主要方法:
- 与12个关键利益相关者进行了采访,包括志愿者,工作人员和套件接收者.
- 包括有实体体验物质相关危害的个人.
- 采用反射主题分析来解释采访数据.
主要成果:
- 有意义地吸引受物质相关危害影响最大的社区成员至关重要.
- 基于优势的危害减轻观点是必不可少的.
- 识别和解决降低危害的障碍,供应分配和降低危害的障碍是很重要的.
结论:
- 调查结果强调了社区参与和基于优势的方法在减少危害方面的重要性.
- 解决系统性障碍对于有效和公平地分配减伤用品至关重要.
- 这项研究为堪萨斯州减少危害的更全面,更全面的方法提供了基础.
更多相关视频
10:35A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
11.2K
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
9.9K
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
255
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
255
Prevention of Further Absorption of Poison
931
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
931
Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
